This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Wagr Syndrome
Information about Wagr Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Wagr Syndrome
Most recent studies have shown that Wagr Syndrome shares some biological mechanisms with aniridia, beckwith-wiedemann-syndrome, cataract, cell-transformation-neoplastic, chromosomal-translocation, congenital-abnormality, cryptorchidism, cytogenetic-abnormality, denys-drash-syndrome, haploinsufficiency, kidney-diseases, kidney-failure-chronic, kidney-neoplasm, loss-of-chromosome-11, malignant-neoplasms, neoplasms, nephroblastoma, obesity, urogenital-abnormalities.
Among the many pathways, these few ones have gauged particular interests from scientists studying Wagr Syndrome, and have been seen in publications frequently: Brain Development, Cell Adhesion, Cell Differentiation, Central Nervous System Development, Diaphragm Development, Energy Homeostasis, Genetic Imprinting, Kidney Development, Localization, Mesenchymal Stem Cell Differentiation, Mitotic Recombination, Nervous System Development, Neurogenesis, Pathogenesis, Spermatogenesis, Stem Cell Differentiation, Synaptic Transmission, System Development, Translation
Quite a number of genes have been found to play important roles in Wagr Syndrome, such as ALDH5A1, BDNF, CAT, CDKN2A, CRAT, DBH, EXOSC1, FSHB, HBB, HRAS, MB, NPHS1, NRAS, PAX6, POMC, S100A10, S100A9, SUB1, WT1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.